close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SPRY

Recent news which mentions SPRY

< Previous 1 2 Next >
ARS Pharma (SPRY) Q4 2025 Earnings Transcript
Tickers SPRY
Tags SPRY Recent Press Releases Market News
From Motley Fool
ARS Pharmaceuticals Q1 2026 Earnings Call Transcript
Tickers NEWS SPRY
Tags Market News Benzinga Earnings Conference Call Transcripts
From Benzinga
Earnings Scheduled For May 15, 2026
Tickers ARAI AZ BCDA BEEM
Tags ARAI NUAI SKLZ
From Benzinga
ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts
Tickers NEWS SPRY
Tags Expert Ideas SPRY Benzinga
From Benzinga
Dow Settles Above 50,000: Investor Sentiment Improves, Fear Index Remains In &#39;Greed&#39; Zone
Tickers CSCO DDS NEWS RBC
Tags SPRY CSCO Benzinga
From Benzinga
ARS Pharma Sales Jump 3,040% in Q2
Tickers SPRY
Tags Recent Press Releases SPRY Market News
From Motley Fool
Earnings Scheduled For August 13, 2025
Tickers AEMD ALLO ALUR ALVO
Tags ATER KMDA NEXN
From Benzinga
Earnings Outlook For ARS Pharmaceuticals
Tickers SPRY
Tags SPRY BZI/EP Benzinga
From Benzinga
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
Tickers BMRN GTLB NEWS OKLO
Tags News GTLB UNP
From Benzinga
Earnings Scheduled For May 14, 2025
Tickers ADCT AEVA AFCG ALUR
Tags CSCO NYXH NVGS
From Benzinga
ARS Pharmaceuticals's Earnings: A Preview
Tickers SPRY
Tags Benzinga Market News Earnings
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Tickers ADAP AKBA BDRX CRVO
Tags OPTN ADAP VERO
From Benzinga
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
Tickers CAPR CLEU CVNA DRI
Tags IMCR CVNA News
From Benzinga
Earnings Scheduled For March 20, 2025
Tickers ACN ADAP ALAR AMPX
Tags NEUE BZUN GLUE
From Benzinga
FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray For Emergency Allergy Treatment
Tickers NEWS SPRY
Tags Briefs FDA News
From Benzinga
Earnings Scheduled For November 13, 2024
Tickers ACXP ADAP AEMD AFCG
Tags DLO LQDA PRPH
From Benzinga
Insights Ahead: ARS Pharmaceuticals's Quarterly Earnings
Tickers SPRY
Tags BZI/EP Market News Earnings
From Benzinga
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
Tickers NEWS SPRY
Tags SPRY Expert Ideas Market News
From Benzinga
Where ARS Pharmaceuticals Stands With Analysts
Tickers SPRY
Tags SPRY Analyst Ratings BZI/AAR
From Benzinga
Analyst Ratings For ARS Pharmaceuticals
Tickers SPRY
Tags Benzinga Market News SPRY
From Benzinga
Newly Approved ARS Pharmaceuticals' Needle-Free Neffy Offers Convenience Over EpiPen For Allergic Reaction, But Real-World Efficacy Questioned
Tickers NEWS SPRY
Tags Top Stories News Health Care
From Benzinga
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
Tickers NEWS SNY SPRY
Tags Top Stories News Briefs
From Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
Tickers AS BTBT FN HA
Tags AS Mid/Day Movers News
From Benzinga
Looking Into ARS Pharmaceuticals's Recent Short Interest
Tickers SPRY
Tags BZI/SHORTHIST Trading Ideas Short Ideas
From Benzinga
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
Tickers AILE ASND CLNE CLVT
Tags Markets PLSE big gainers
From Benzinga
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
Tickers NEWS SNY SPRY
Tags FDA Briefs why it's moving
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today